Your browser doesn't support javascript.
loading
Type 2 inflammation in eosinophilic chronic obstructive pulmonary disease.
Higham, Andrew; Beech, Augusta; Wolosianka, Sophie; Jackson, Natalie; Long, Gabriella; Kolsum, Umme; Southworth, Thomas; Pham, Tuyet-Hang; Sridhar, Sriram; McCrae, Christopher; Newbold, Paul; Singh, Dave.
Afiliación
  • Higham A; Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, The University of Manchester, Manchester University NHS Foundations Trust, Manchester, UK.
  • Beech A; Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, The University of Manchester, Manchester University NHS Foundations Trust, Manchester, UK.
  • Wolosianka S; Medicines Evaluation Unit, Manchester, UK.
  • Jackson N; Medicines Evaluation Unit, Manchester, UK.
  • Long G; Medicines Evaluation Unit, Manchester, UK.
  • Kolsum U; Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, The University of Manchester, Manchester University NHS Foundations Trust, Manchester, UK.
  • Southworth T; Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, The University of Manchester, Manchester University NHS Foundations Trust, Manchester, UK.
  • Pham TH; Medicines Evaluation Unit, Manchester, UK.
  • Sridhar S; Translational Science & Experimental Medicine, Early Respiratory & Immunology, Research and Early Development, AstraZeneca, Gaithersburg, MD, USA.
  • McCrae C; Translational Science, Oncology R&D, AstraZeneca, Gaithersburg, MD, USA.
  • Newbold P; Translational Science & Experimental Medicine, Early Respiratory & Immunology, Research and Early Development, AstraZeneca, Gaithersburg, MD, USA.
  • Singh D; Biopharmaceuticals Medical, AstraZeneca, Gaithersburg, MD, USA.
Allergy ; 76(6): 1861-1864, 2021 06.
Article en En | MEDLINE | ID: mdl-33206402
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedad Pulmonar Obstructiva Crónica Tipo de estudio: Diagnostic_studies Límite: Humans Idioma: En Revista: Allergy Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedad Pulmonar Obstructiva Crónica Tipo de estudio: Diagnostic_studies Límite: Humans Idioma: En Revista: Allergy Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido